I-Mab Reports Third Quarter 2024 Results - Nasdaq

Sep 30, 2024  · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …


Install CouponFollow Chrome Extension   CouponFollow Extension

$184
OFF

I-Mab Reports Third Quarter 2024 Results - Nasdaq

2 weeks from now

Sep 30, 2024  · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …

nasdaq.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results - Morningstar

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

morningstar.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

i-mabbiopharma.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results - Yahoo Finance

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

yahoo.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results - BioSpace

2 weeks from now

18 hours ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

biospace.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results | Citybiz

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

citybiz.co

$184
OFF

I Mab : Reports Third Quarter 2024 Results Form 6 K

2 weeks from now

1 day ago  · Estimated cash runway into 2027, based on $184.4 million in cash and cash equivalents, and short-term investments as of September 30, 2024. ROCKVILLE, MD, …

marketscreener.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results - PR Newswire

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

prnewswire.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results | EPICOS

2 weeks from now

1 day ago  · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …

epicos.com

$102344
OFF

IDenta Corp Reports Third Quarter 2024 Results With 100

2 weeks from now

1 day ago  · Net profit for the third quarter of 2024 was $102,344 compared to net profit of ($22,837) in the third quarter of 2023. Cash and cash equivalents increased to $469,615 for …

nasdaq.com

$4.94
OFF

ALT5 Sigma Reports Fiscal Financial Results For Third Quarter 2024 …

2 weeks from now

2 days ago  · Nov 12, 2024 4:50pm EST. Record quarter for ALT5 with Q3 revenue of $4.94 million. New customer onboarding strong in Q3 and continuing into Q4. Launching additional …

nasdaq.com

$648
OFF

ITeos Reports Third Quarter 2024 Financial Results And

2 weeks from now

3 days ago  · Third Quarter 2024 Financial Results. Cash and Investment Position: The Company’s cash, cash equivalents, and investments position was $648.9 million as of …

globenewswire.com

$184
OFF

I-Mab Reports Third Quarter 2024 Results

2 weeks from now

1 day ago  · Rhea-AI Summary. I-Mab (NASDAQ: IMAB) reported Q3 2024 financial results and pipeline updates. The company ended Q3 with $184.4 million in cash and equivalents, …

stocktitan.net

$9.35
OFF

Gambling.com Group Reports Third Quarter 2024 Results

2 weeks from now

1 day ago  · Third Quarter 2024 and Recent Business Highlights Delivered more than 116,000 new depositing customers (“NDCs”) Repurchased 1,316,975 shares at an average price of $9.35 …

businesswire.com

€99
OFF

Ascendis Pharma Reports Third Quarter 2024 Financial Results

2 weeks from now

21 hours ago  · The change was primarily tied the impact of currency fluctuations. For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share …

globenewswire.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension